Improving dietary patterns in patients with nonalcoholic fatty liver disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 5, 2012, Pages 468-473

  Carvalhana, Sofia ^a   MacHado, Mariana Verdelho ^a   Cortez Pinto, Helena ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FRUCTOSE; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID;

ALCOHOL CONSUMPTION; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; COFFEE; DIET; FAT INTAKE; FOOD INTAKE; HUMAN; LIFESTYLE MODIFICATION; NONALCOHOLIC FATTY LIVER; REVIEW; TEA; WEIGHT REDUCTION;

ALCOHOL DRINKING; CALORIC RESTRICTION; CHOLESTEROL; COFFEE; DIET; DIETARY FATS; ETHANOL; FATTY ACIDS; FATTY LIVER; FRUCTOSE; HUMANS; LIVER; TEA;

EID: 84865507594     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283566614     Document Type: Review

References (63)

1. Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study. Hepatology 2005; 42:44-52. (Pubitemid 40911310)
2. Zelber-Sagi S, Lotan R, Shlomai A, et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 2012; 56:1145-1151.
3. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary nonalcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006; 26:856-863. (Pubitemid 44165254)
4. Bedard D, Shatenstein B, Nadon S. Underreporting of energy intake from a self-administered food-frequency questionnaire completed by adults in montreal. Public Health Nutr 2004; 7:675-681. (Pubitemid 39049982)
5. Kechagias S, Ernersson A, Dahlqvist O, et al. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 2008; 57:649-654. (Pubitemid 351579979)
6. Brons C, Jensen CB, Storgaard H, et al. Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol 2009; 587:2387-2397.
7. van der Meer RW, Hammer S, Lamb HJ, et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 2008; 93:2702-2708. (Pubitemid 352008539)
8. LêKA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009; 89:1760-1765.
9. Kirk E, Reeds DN, Finck BN, et al. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009; 136:1552-1560.
10. Sobrecases H, LêKA, Bortolotti M, et al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab 2010; 36:244-246.
11. Haufe S, Engeli S, Kast P, et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011; 53:1504-1514.
12. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of nonalcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012; 56:255-266.
13. Benjaminov O, Beglaibter N, Gindy L, et al. The effect of a low-carbohydrate diet on the nonalcoholic fatty liver in morbidly obese patients before bariatric surgery. Surg Endosc 2007; 21:1423-1427. (Pubitemid 47125051)
14. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in nonalcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55:885-904.
15. Westerbacka J, Lammi K, Häkkinen AM, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005; 90:2804-2809. (Pubitemid 40686327)
16. Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37:909-916. (Pubitemid 36397404)
17. Cortez-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in nonalcoholic steatohepatitis patients? Clin Nutr 2006; 25:816-823. (Pubitemid 44426431)
18. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for nonalcoholic fatty liver disease (nafld): a population based study. J Hepatol 2007; 47:711-717. (Pubitemid 47503432)
19. Yasutake K, Nakamuta M, Shima Y, et al. Nutritional investigation of nonobese patients with nonalcoholic fatty liver disease: The significance of dietary cholesterol. Scand J Gastroenterol 2009; 44:471-477.
20. Caballero F, Fernández A, De Lacy AM, et al. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol 2009; 50:789-796.
21. Vinaixa M, Rodriguez MA, Rull A, et al. Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J Proteome Res 2010; 9:2527-2538.
22. Subramanian S, Goodspeed L, Wang S, et al. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 2011; 52:1626-1635.
23. Van Rooyen DM, Larter CZ, Haigh WG, et al. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 2011; 141:1393-1403.
24. Stamler J. Diet-heart: a problematic revisit. Am J Clin Nutr 2010; 91:497-499.
25. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91:535-546.
26. Toshimitsu K, Matsuura B, Ohkubo I, et al. Dietary habits and nutrient intake in nonalcoholic steatohepatitis. Nutrition 2007; 23:46-52. (Pubitemid 44959764)
27. Romestaing C, Piquet M-A, Bedu E, et al. Long term highly saturated fat diet does not induce nash in wistar rats. Nutr Metab 2007; 4:4.
28. Machado MV, Ravasco P, Jesus L, et al. Blood oxidative stress markers in nonalcoholic steatohepatitis and how it correlates with diet. Scand J Gastroenterol 2008; 43:95-102.
29. Cao J, Dai DL, Yao L, et al. Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway. Mol Cell Biochem 2012; 364:115-129.
30. Lin J, Yang R, Tarr PT, et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005; 120:261-273. (Pubitemid 40174768)
31. Abete I, Goyenechea E, Zulet MA, Martínez JA. Obesity and metabolic syndrome: Potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 2011; 21 (Suppl 2):B1-B15.
32. Pettinelli P, Del Pozo T, Araya J, et al. Enhancement in liver SREBP-1c/PPARalpha ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long chain polyunsaturated fatty acid depletion. Biochim Biophys Acta-Mol Basis Dis 2009; 1792:1080-1086.
33. Parker HM, Johnson NA, Burdon C, et al. Omega-3 supplementation and nonalcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol 2011; 56:944-951.
34. Gillingham LG, Harris-Janz S, Jones PJ. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 2011; 46:209-228.
35. Hussein O, Grosovski M, Lasri E, et al. Monounsaturated fat decreases hepatic lipid content in nonalcoholic fatty liver disease in rats. World J Gastroenterol 2007; 13:361-368. (Pubitemid 46178969)
36. Koppe SW, Elias M, Moseley RH, Green RM. Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. Am J Physiol Gastrointest Liver Physiol 2009; 297:G378-G384.
37. Sun Q, Ma J, Campos H, et al. A prospective study of trans fatty acids in erytrocites and risk of coronary heart disease. Circulation 2007; 115:1858-1865. (Pubitemid 46598899)
38. Machado RM, Stefano JT, Oliveira CP, et al. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. J Nutr 2010; 140:1127-1132.
39. Dhibi M, Brahmi F, Mnari A, et al. The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. Nutr Metab 2011; 8:65.
40. Brighenti F, Benini L, Del Rio D, et al. Colonic fermentation of indigestible carbohydrates contributes to the second-meal effect. Am J Clin Nutr 2006; 83:817-822. (Pubitemid 44713145)
41. Nielsen SJ, Popkin BM. Changes in beverage intake between 1977 and 2001. Am J Prev Med 2004; 27:205-210. (Pubitemid 39278319)
42. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119:1322-1334.
43. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292:927-934. (Pubitemid 39097202)
44. Abdelmalek MF, Suzuki A, Guy C, et al. Nonalcoholic steatohepatis clinical research network. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51:1961-1971.
45. Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 2012; 23:203-208.
46. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16:2579-2588.
47. Ngo Sock ET, LêKA, Ith M, et al. Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br J Nutr 2010; 103:939-943.
48. Klein EA, Thompson IM, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306:1549-1556.
49. Moriya A, Iwasaki Y, Ohguchi S, et al. Alcohol consumption appears to protect against nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2011; 33:378-388.
50. Marks P, Williams R. Calorie and alcohol consumption in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2012; 24:527-530.
51. Cotrim HP, Freitas LA, Alves E, et al. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur J Gastroenterol Hepatol 2009; 21:969-972.
52. Ekstedt M, Franzén LE, Holmqvist M, et al. Alcohol consumption is associated with progression of hepatic fibrosis in nonalcoholic fatty liver disease. Scand J Gastroenterol 2009; 44:366-374.
53. Ascha MS, Hanouneh IA, Lopez R, et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51:1972-1978.
54. Panchal SK, Poudyal H, Waanders J, Brown L. Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr 2012; 142:690-697.
55. Vitaglione P, Morisco F, Mazzone G, et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010; 52:1652-1661.
56. Molloy JW, Calcagno CJ, Williams CD, et al. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012; 55:429-436.
57. Birerdinc A, Stepanova M, Pawloski L, Younossi ZM. Caffeine is protective in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2012; 35:76-82.
58. Karmakar S, Das D, Maiti A, et al. Black tea prevents high fat dietinduced nonalcoholic steatohepatitis. Phytother Res 2011; 25:1073-1081. A study with rats with diet-induced NAFLD supplemented with blact tea extracts. Supplementation prevented steatohepatitis and shifted redox status to an antioxidant profile.
59. Bruno RS, Dugan CE, Smyth JA, et al. Green tea extract protects leptindeficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 2008; 138:323-331. (Pubitemid 351213647)
60. Park HJ, Lee J-Y, Chung M-Y, et al. Green tea extract suppresses nfkb activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J Nutr 2012; 142:57-63.
61. Chung M-Y, Park HJ, Manautou JE, et al. Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem 2012; 23:361-367. A similar study evaluating green tea extracts in a different animal model of NAFLD, but with similar results in terms of hepatic histology.
62. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995; 310:693-696.
63. Masterjohn C, Bruno RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev 2012; 70:41-56.